Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Identification and classification of chromosomal aberrations in human induced pluripotent stem cells.

Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B, Clark AT, Plath K, Lowry WE, Benvenisty N.

Cell Stem Cell. 2010 Oct 8;7(4):521-31. doi: 10.1016/j.stem.2010.07.017.

2.

Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells.

Ruiz S, Diep D, Gore A, Panopoulos AD, Montserrat N, Plongthongkum N, Kumar S, Fung HL, Giorgetti A, Bilic J, Batchelder EM, Zaehres H, Kan NG, Schöler HR, Mercola M, Zhang K, Izpisua Belmonte JC.

Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16196-201. doi: 10.1073/pnas.1202352109. Epub 2012 Sep 18.

3.

Human embryonic stem cells as models for aneuploid chromosomal syndromes.

Biancotti JC, Narwani K, Buehler N, Mandefro B, Golan-Lev T, Yanuka O, Clark A, Hill D, Benvenisty N, Lavon N.

Stem Cells. 2010 Sep;28(9):1530-40. doi: 10.1002/stem.483.

4.

Screening of human pluripotent stem cells using CGH and FISH reveals low-grade mosaic aneuploidy and a recurrent amplification of chromosome 1q.

Dekel-Naftali M, Aviram-Goldring A, Litmanovitch T, Shamash J, Reznik-Wolf H, Laevsky I, Amit M, Itskovitz-Eldor J, Yung Y, Hourvitz A, Schiff E, Rienstein S.

Eur J Hum Genet. 2012 Dec;20(12):1248-55. doi: 10.1038/ejhg.2012.128. Epub 2012 Jun 20.

5.

Gene and MicroRNA Profiling of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells.

Wang L, Su W, Du W, Xu Y, Wang L, Kong D, Han Z, Zheng G, Li Z.

Stem Cell Rev. 2015 Apr;11(2):219-27. doi: 10.1007/s12015-014-9582-4.

PMID:
25618294
6.

Aneuploidy is permissive for hepatocyte-like cell differentiation from human induced pluripotent stem cells.

Noto FK, Determan MR, Cai J, Cayo MA, Mallanna SK, Duncan SA.

BMC Res Notes. 2014 Jul 8;7:437. doi: 10.1186/1756-0500-7-437.

7.

The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture.

Tesarova L, Simara P, Stejskal S, Koutna I.

PLoS One. 2016 Jun 23;11(6):e0157974. doi: 10.1371/journal.pone.0157974. eCollection 2016.

8.

Genetic and epigenetic instability in human pluripotent stem cells.

Nguyen HT, Geens M, Spits C.

Hum Reprod Update. 2013 Mar-Apr;19(2):187-205. doi: 10.1093/humupd/dms048. Epub 2012 Dec 7. Review.

PMID:
23223511
9.
10.

The tumorigenicity of diploid and aneuploid human pluripotent stem cells.

Blum B, Benvenisty N.

Cell Cycle. 2009 Dec;8(23):3822-30. Epub 2009 Dec 14. Review.

PMID:
19887907
11.

Development of a protein marker panel for characterization of human induced pluripotent stem cells (hiPSCs) using global quantitative proteome analysis.

Pripuzova NS, Getie-Kebtie M, Grunseich C, Sweeney C, Malech H, Alterman MA.

Stem Cell Res. 2015 May;14(3):323-38. doi: 10.1016/j.scr.2015.01.009. Epub 2015 Feb 7.

12.

Identification of unsafe human induced pluripotent stem cell lines using a robust surrogate assay for pluripotency.

Polanco JC, Ho MS, Wang B, Zhou Q, Wolvetang E, Mason E, Wells CA, Kolle G, Grimmond SM, Bertoncello I, O'Brien C, Laslett AL.

Stem Cells. 2013 Aug;31(8):1498-510. doi: 10.1002/stem.1425.

13.

An atypical human induced pluripotent stem cell line with a complex, stable, and balanced genomic rearrangement including a large de novo 1q uniparental disomy.

Steichen C, Maluenda J, Tosca L, Luce E, Pineau D, Dianat N, Hannoun Z, Tachdjian G, Melki J, Dubart-Kupperschmitt A.

Stem Cells Transl Med. 2015 Mar;4(3):224-9. doi: 10.5966/sctm.2014-0186. Epub 2015 Feb 3.

14.

Genomic analysis of hESC pedigrees identifies de novo mutations and enables determination of the timing and origin of mutational events.

Ben-Yosef D, Boscolo FS, Amir H, Malcov M, Amit A, Laurent LC.

Cell Rep. 2013 Sep 26;4(6):1288-302. doi: 10.1016/j.celrep.2013.08.009. Epub 2013 Sep 12.

15.

High prevalence of evolutionarily conserved and species-specific genomic aberrations in mouse pluripotent stem cells.

Ben-David U, Benvenisty N.

Stem Cells. 2012 Apr;30(4):612-22. doi: 10.1002/stem.1057.

16.

A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs.

Choi J, Lee S, Mallard W, Clement K, Tagliazucchi GM, Lim H, Choi IY, Ferrari F, Tsankov AM, Pop R, Lee G, Rinn JL, Meissner A, Park PJ, Hochedlinger K.

Nat Biotechnol. 2015 Nov;33(11):1173-81. doi: 10.1038/nbt.3388. Epub 2015 Oct 26.

17.

Mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations.

Prigione A, Hossini AM, Lichtner B, Serin A, Fauler B, Megges M, Lurz R, Lehrach H, Makrantonaki E, Zouboulis CC, Adjaye J.

PLoS One. 2011;6(11):e27352. doi: 10.1371/journal.pone.0027352. Epub 2011 Nov 14.

18.

Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.

Mosca E, Cocola C, Sabour D, Pelucchi P, Bertalot G, Palumbo O, Carella M, Götte M, Schöler HR, Reinbold R, Zucchi I, Milanesi L.

In Silico Biol. 2010;10(5-6):207-21. doi: 10.3233/ISB-2010-0437.

PMID:
22430355
19.

Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression.

Uosaki H, Fukushima H, Takeuchi A, Matsuoka S, Nakatsuji N, Yamanaka S, Yamashita JK.

PLoS One. 2011;6(8):e23657. doi: 10.1371/journal.pone.0023657. Epub 2011 Aug 18.

20.

Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cells.

Bruck T, Benvenisty N.

Stem Cell Res. 2011 Mar;6(2):187-93. doi: 10.1016/j.scr.2010.12.001. Epub 2010 Dec 13.

Supplemental Content

Support Center